Stock Events

Stock Events

Edesa Biotech 

$5.71
11
+$0.06+1.06% Tuesday 20:00
+$0.38+6.59%Tuesday 23:40After hours

Statistics

Day High
6.3
Day Low
5.65
52W High
20.32
52W Low
0.72
Volume
45,587
Avg. Volume
157,851
Mkt Cap
55.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.6
-0.48
-0.37
-0.25
Expected EPS
-0.435
Actual EPS
-0.6

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-7.19MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EDSA. It's not an investment recommendation.
Tesla
4
TSLA
Netflix
4
NFLX
Apple
3
AAPL
Microsoft
3
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap25.28B
Moderna is involved in developing mRNA-based therapies, a field that overlaps with Edesa Biotech's focus on innovative treatments, making them direct competitors in the biotech space.
BioNTech
BNTX
Mkt Cap23.38B
BioNTech competes in the development of novel therapies, including mRNA vaccines and treatments, directly challenging Edesa Biotech's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals is a leader in biopharmaceuticals, focusing on immunology and inflammation, areas that Edesa Biotech is also targeting.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is a biopharmaceutical company with a strong presence in antiviral drugs and treatments for inflammatory and respiratory diseases, competing with Edesa Biotech's research focus.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotech firm with a broad portfolio, including treatments for inflammatory diseases, which puts it in competition with Edesa Biotech's therapeutic areas.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie operates in similar therapeutic areas as Edesa Biotech, including immunology and chronic diseases, making them competitors in the biopharmaceutical field.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a global pharmaceutical company with a wide range of products, including vaccines and biologics that compete with Edesa Biotech's developments.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical division Janssen, develops treatments that overlap with Edesa Biotech's focus areas, particularly in immunology.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company with a strong emphasis on research and development in areas like dermatology and rheumatology, competing with Edesa Biotech.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca has a diverse biopharmaceutical portfolio, including treatments for respiratory and autoimmune diseases, making it a competitor to Edesa Biotech.

About

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Show more...
CEO
Pardeep Nijhawan
Employees
17
Country
Canada
ISIN
CA27966L3065

Listings

XNAS
US
EDSA
STU
DE
RBTQ.STU
BOATS
BOATS
EDSA.BOATS

0 Comments

Share your thoughts

FAQ

What is Edesa Biotech stock price today?▼
The current price of EDSA is $5.71 USD — it has increased by +1.06% in the past 24 hours. Watch Edesa Biotech stock price performance more closely on the chart.
What is Edesa Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Edesa Biotech stocks are traded under the ticker EDSA.
Is Edesa Biotech stock price growing?▼
EDSA stock has risen by +7.74% compared to the previous week, the month change is a -13.48% fall, over the last year Edesa Biotech has showed a +146.12% increase.
What is Edesa Biotech market cap?▼
Today Edesa Biotech has the market capitalization of 55.01M
When is the next Edesa Biotech earnings date?▼
Edesa Biotech is going to release the next earnings report on December 11, 2026.
What were Edesa Biotech earnings last quarter?▼
EDSA earnings for the last quarter are -0.6 USD per share, whereas the estimation was -0.44 USD resulting in a -37.93% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Edesa Biotech revenue for the last year?▼
Edesa Biotech revenue for the last year amounts to 0 USD.
What is Edesa Biotech net income for the last year?▼
EDSA net income for the last year is -7.19M USD.
How many employees does Edesa Biotech have?▼
As of August 19, 2026, the company has 17 employees.
In which sector is Edesa Biotech located?▼
Edesa Biotech operates in the Health & Wellness sector.
When did Edesa Biotech complete a stock split?▼
The last stock split for Edesa Biotech was on October 11, 2023 with a ratio of 1:7.
Where is Edesa Biotech headquartered?▼
Edesa Biotech is headquartered in MARKHAM, Canada.